Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Treace Medical Concepts Inc (TMCI)

Treace Medical Concepts Inc (TMCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Treace Medical Concepts Inc 100 Palmetto Park Place PONTE VEDRA FL 32081 USA

www.treace.com Employees: 516 P: 904-373-5940 F: 904-834-7169

Description:

Treace Medical Concepts Inc. is a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus. Treace Medical Concepts Inc. is based in PONTE VEDRA, Fla.

Key Statistics

Overview:

Market Capitalization, $K 297,268
Enterprise Value, $K 337,298
Shares Outstanding, K 62,190
Annual Sales, $ 187,120 K
Annual Net Income, $ -49,530 K
Last Quarter Sales, $ 44,460 K
Last Quarter Net Income, $ -21,210 K
EBIT, $ -64,950 K
EBITDA, $ -60,710 K
60-Month Beta 0.24
% of Insider Shareholders 24.43%
% of Institutional Shareholders 84.08%
Float, K 46,997
% Float 75.57%
Short Volume Ratio 0.40

Growth:

1-Year Return -52.67%
3-Year Return -79.95%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.34 on 08/06/24
Next Earnings Date 11/05/24 [AMC]
Earnings Per Share ttm -1.02
EPS Growth vs. Prev Qtr -13.33%
EPS Growth vs. Prev Year -70.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TMCI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -49.53%
Return-on-Assets % -26.51%
Profit Margin % -26.47%
Debt/Equity 0.47
Price/Sales 1.55
Price/Cash Flow N/A
Price/Book 2.58
Book Value/Share 1.81
Interest Coverage -8.58
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar